While the benefits of AI are clear, says one stakeholder, trust remains the biggest impediment to the widespread adoption and use of AI in the clinical setting.

Designed to work across many different types of biomedical information, stakeholders say Terra simplifies a range of processes so, among other outcomes, researchers can analyze and share data they have generated.

Since it launched, say stakeholders, CHI Franciscan’s Mission Control has had tremendous success managing capacity, transfers, patient placement and staffing, all in the middle of a pandemic.